JOHN E. FRIEND II, MD

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cellectar Biosciences, Inc.

Filing Date Source Excerpt
2018-06-11 Name and Address of Beneficial Owner John E. Friend II, MD Outstanding 100,000 Right to Acquire — Total 100,000 *.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09